Ana Luisa Perdigoto
- Virology top 5%
- HIV Research and Treatment 3
-
- Diabetes Management and Research 5
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 14
- Pancreatic and Hepatic Oncology Research 3
- Genetics top 5%
- Diabetes and associated disorders 11
- Immunology top 10%
- Immune Cell Function and Interaction 7
-
- Pancreatic function and diabetes 8
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Kevan C. HeroldHarriet M. KlugerMark S. AndersonZoe QuandtJeffrey A. BluestonePamela ClarkArabella YoungSarah A. Weiss
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Ana Luisa Perdigoto
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Virology 110
- Endocrinology, Diabetes and Metabolism 329
- Oncology 535
- Genetics 494
- Immunology 346
Countries citing papers authored by Ana Luisa Perdigoto
This map shows the geographic impact of Ana Luisa Perdigoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Luisa Perdigoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Luisa Perdigoto more than expected).
Fields of papers citing papers by Ana Luisa Perdigoto
This network shows the impact of papers produced by Ana Luisa Perdigoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Luisa Perdigoto. The network helps show where Ana Luisa Perdigoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Luisa Perdigoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | The immunology of type 1 diabetesbreakdown → | 2024 | 81 |
| 6 | 2023 | 19 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 47 | |
| 9 | 2022 | 25 | |
| 10 | 2021 | 84 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 40 | |
| 13 | 2019 | 29 | |
| 14 | 2019 | 13 | |
| 15 | 2018 | 85 | |
| 16 | 2017 | 7 | |
| 17 | 2016 | 3 | |
| 18 | 2013 | 54 | |
| 19 | 2010 | 23 | |
| 20 | 2009 | 97 |
About Ana Luisa Perdigoto
Ana Luisa Perdigoto is a scholar working on Virology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Diabetes and associated disorders (11 papers), Pancreatic function and diabetes (8 papers), Immune Cell Function and Interaction (7 papers), Diabetes Management and Research (5 papers), HIV Research and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Virology (110 citations), Endocrinology, Diabetes and Metabolism (329 citations) and Oncology (535 citations). Ana Luisa Perdigoto has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Kevan C. Herold, Harriet M. Kluger, Mark S. Anderson, Zoe Quandt, Jeffrey A. Bluestone, Pamela Clark, Arabella Young, Sarah A. Weiss, Mario Sznol and Jinxiu Rui. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.